Drug intelligence / Profile preview

Qinlian Jiangxia decoction

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Qinlian Jiangxia decoction (QLJXD) is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its therapeutic potential in treating type 2 diabetes mellitus (T2DM) complicated by hyperlipidemia. The decoction is a multi-component mixture typically containing botanical ingredients such as *Scutellaria baicalensis* (Huangqin) and *Coptis chinensis* (Huanglian). Research utilizing network pharmacology, molecular docking, and molecular dynamics simulations suggests that QLJXD exerts its effects through a multi-target approach, primarily modulating the PI3K/Akt signaling pathway to improve glucose and lipid metabolism. It is also thought to regulate inflammatory cytokines and improve insulin sensitivity, thereby addressing the metabolic dysregulation characteristic of comorbid diabetes and dyslipidemia.

Other names
Qinlian Jiangxia formula
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)FABP4 (Fatty acid-binding protein 4)IL-6 (Interleukin 6)AKT (RAC-alpha serine/threonine-protein kinase)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Qinlian Jiangxia decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinlian Jiangxia decoction.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call